Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum
A Phase 2 clinical trial has started of DS-1211 in individuals with Pseudoxanthoma Elasticum (PXE), a rare multisystem genetic disease that causes calcium deposits in soft tissue resulting in considerable morbidity.
Source: news-medical.net